SinoMab BioScience Announces Proposed Listing on the Main Board of SEHK
- Written by ACN Newswire - Press Releases
HONG KONG, Oct 30, 2019 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological
Read more //?#